BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
VALENCIA, Calif. and TAMPA, Fla., March 08, 2017 -- MannKind Corporation and Bella & Elle Media LLC announce MannKind’s sponsorship of “Reversed,” a production series aimed at educating the show’s participants and viewing audience about the effects of poorly managed diabetes and its impact on their lives. “Reversed” will air on Discovery Life Channel in the summer of 2017.
|
|||
“Reversed” was created by Celebrity Chef and Diabetes Advocate, Charles Mattocks. The award-winning producer and bestselling author will host “Reversed,” as it follows the lives of individuals affected by diabetes and their struggle to change their diet, exercise and mindset about the disease. “Reversed” will feature experts such as diabetes educators, endocrinologists, therapists, nutritionists, and trainers, as well as celebrity guests who are also living with diabetes, to help encourage the contestants.
Charles Mattocks, nephew of legendary Bob Marley, said, “My uncle made an impact on the world through music and my vision is to impact health. 'Reversed' is about changing the behavior of those with diabetes. I am excited that MannKind has joined 'Reversed' in our mission."
Michael Castagna, Chief Commercial Officer of MannKind Corporation, added, “MannKind is continually seeking platforms to increase awareness around the challenges, opportunities and success people living with diabetes encounter on a daily basis. Mr. Mattock’s educational platforms, which have been featured on CNN, Dr. Oz and The Today Show, showcase the strength and determination of people fighting to make their lives better as they fight diabetes. We are excited to be associated with Mr. Mattock’s continuing efforts to educate the public.”
ABOUT MANNKIND CORPORATION
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
ABOUT BELLA & ELLE MEDIA LLC
For more information visit www.reversedyourhealth.com and sign up for updates on the show and the other work being done to help educate and empower individuals affected by this disease. Questions about the movement that is REVERSED can be directed to Charles Mattocks at [email protected].
MannKind Contact: Rose Alinaya SVP, Finance 661-775-5300 [email protected] Bella & Elle Media LLC Contact: Charles Mattocks 201-755-5386 [email protected]
